Wolverine Trading’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $83.5M | Buy |
374,200
+115,300
| +45% | +$23.5M | 0.06% | 215 |
|
|
2025
Q2 | $47.2M | Buy |
+258,900
| New | +$48.1M | 0.05% | 263 |
|
|
2025
Q1 | – | Sell |
-323,700
| Closed | -$57M | – | 4629 |
|
|
2024
Q4 | $57M | Buy |
323,700
+64,800
| +25% | +$11.9M | 0.05% | 208 |
|
|
2024
Q3 | $50.4M | Sell |
258,900
-114,000
| -31% | -$21.3M | 0.05% | 205 |
|
|
2024
Q2 | $64M | Buy |
372,900
+72,400
| +24% | +$12M | 0.07% | 159 |
|
|
2024
Q1 | $54.7M | Hold |
300,500
| – | – | 0.06% | 174 |
|
|
2023
Q4 | $46.6M | Buy |
300,500
+54,000
| +22% | +$7.87M | 0.05% | 232 |
|
|
2023
Q3 | $36.7M | Sell |
246,500
-1,800
| -0.7% | -$264K | 0.04% | 208 |
|
|
2023
Q2 | $33.1M | Buy |
248,300
+14,900
| +6% | +$2.18M | 0.04% | 237 |
|
|
2023
Q1 | $36.9M | Sell |
233,400
-761,800
| -77% | -$116M | 0.06% | 205 |
|
|
2022
Q4 | $161M | Buy |
995,200
+805,700
| +425% | +$124M | 0.24% | 47 |
|
|
2022
Q3 | $27M | Sell |
189,500
-6,100
| -3% | -$875K | 0.04% | 239 |
|
|
2022
Q2 | $30.1M | Sell |
195,600
-75,600
| -28% | -$11.6M | 0.05% | 212 |
|
|
2022
Q1 | $44.4M | Sell |
271,200
-196,800
| -42% | -$28.6M | 0.06% | 210 |
|
|
2021
Q4 | $63.6M | Buy |
468,000
+105,400
| +29% | +$12.5M | 0.08% | 174 |
|
|
2021
Q3 | $39.5M | Sell |
362,600
-101,300
| -22% | -$11.6M | 0.04% | 298 |
|
|
2021
Q2 | $52.1M | Buy |
463,900
+106,300
| +30% | +$12M | 0.08% | 179 |
|
|
2021
Q1 | $38.2M | Sell |
357,600
-23,000
| -6% | -$2.46M | 0.06% | 224 |
|
|
2020
Q4 | $40.1M | Buy |
380,600
+61,900
| +19% | +$5.95M | 0.06% | 205 |
|
|
2020
Q3 | $27.7M | Buy |
318,700
+53,400
| +20% | +$5.03M | 0.07% | 207 |
|
|
2020
Q2 | $25.6M | Sell |
265,300
-121,200
| -31% | -$10.7M | 0.07% | 184 |
|
|
2020
Q1 | $29.1M | Sell |
386,500
-75,100
| -16% | -$6.4M | 0.09% | 147 |
|
|
2019
Q4 | $40.9M | Buy |
461,600
+116,500
| +34% | +$9.67M | 0.1% | 147 |
|
|
2019
Q3 | $25.8M | Buy |
345,100
+72,800
| +27% | +$4.99M | 0.07% | 206 |
|
|
2019
Q2 | $19.8M | Sell |
272,300
-70,900
| -21% | -$5.57M | 0.06% | 293 |
|
|
2019
Q1 | $27.7M | Buy |
343,200
+18,900
| +6% | +$1.55M | 0.08% | 184 |
|
|
2018
Q4 | $29.6M | Buy |
324,300
+42,400
| +15% | +$3.73M | 0.08% | 161 |
|
|
2018
Q3 | $26.7M | Sell |
281,900
-82,100
| -23% | -$7.79M | 0.06% | 222 |
|
|
2018
Q2 | $34.5M | Hold |
364,000
| – | – | 0.08% | 149 |
|
|
2018
Q1 | $34.5M | Sell |
364,000
-45,600
| -11% | -$5.01M | 0.08% | 149 |
|
|
2017
Q4 | $39.6M | Buy |
+409,600
| New | +$38.6M | 0.14% | 113 |
|
|
2017
Q2 | – | Sell |
-338,900
| Closed | -$22.2M | – | 4184 |
|
|
2017
Q1 | $22.2M | Buy |
338,900
+5,700
| +2% | +$358K | 0.12% | 157 |
|
|
2016
Q4 | $20.9M | Buy |
333,200
+159,300
| +92% | +$9.72M | 0.1% | 196 |
|
|
2016
Q3 | $10.9M | Sell |
173,900
-36,700
| -17% | -$2.38M | 0.05% | 406 |
|
|
2016
Q2 | $13M | Buy |
+210,600
| New | +$12.8M | 0.07% | 269 |
|
Other funds holding ABBV
Wolverine Trading's ABBV Position: Q3 2025 in Review
Wolverine Trading reduced its AbbVie (ABBV) stake by 58% in Q3 2025, selling an estimated $1.23M and leaving 4,298 shares worth $959K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.
Wolverine Trading first reported a position in ABBV in Q2 2016 and has held it in 33 quarters since. The position peaked at $132M in Q4 2022. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Wolverine Trading held 4,298 shares of AbbVie worth $959K as of Q3 2025.
- Wolverine Trading sold 6,058 AbbVie shares in Q3 2025, an estimated $1.23M.
- AbbVie made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2946 holding.
- Wolverine Trading first reported a position in AbbVie in Q2 2016 and has held it in 33 quarters since.
- Wolverine Trading's AbbVie position peaked at $132M in Q4 2022.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.